![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Tiroch Klaus A Byrne Robert A Kastrati Adnan
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.11, Iss.11, 2010-08, pp. : 1855-1872
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacological treatment for prevention of restenosis
By Linde Jacek Strauss Bradley H
Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
By Hamon M.
Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prevention of restenosis with antioxidants
Inpharma, Vol. 1, Iss. 1358, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of drugs in prevention of coronary restenosis
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :